MEDPLUSMedplus Health Services Limited Forensic Risk Analysis

Pharmacy Retail
Risk ClassStable
Market Cap₹10,164 Cr
Primary DriverGovernance
Flagium AI Risk Score
Stable structural profile. Financial profile appears resilient.
0 / 100
-5 QoQ
Improving
Sentinel Insight

Financial profile remains stable for now. Pressure is receding in governance. This indicates that forensic pressure is currently receding. Risk levels are improving.

0.0th %ile (Sector)Accel: +0 Qtrs
Updated2026-06-02
Market View
₹900.15▲2.92%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

No active forensic penalties contributing.
Final Composite Risk0 / 100

Investment Risk Thesis

Historical Trend

Current risk score has declined from 10 → 0 over 13 quarters.

Expected Direction
🟢 Improving
Primary Deterioration Drivers
  • Relative Growth Weakness
  • Low Interest Coverage
What to Watch Next Quarter
  • Operating profit margins

Active Risk Objects (2)

CriticalHigh
Relative Growth Weakness
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight12/15
MomentumAccelerating
Last SignalQ2 FY2026
Revenue growth consistently lags behind sector median (11.0%).

"Early signs of earnings quality decay. Profitability is being driven by non-core items."

Low Interest Coverage
💧 Liquidity & CoverageQuarterlyActive for 4 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ1 FY2025
MEDPLUS: Low Interest Coverage Ratio of 1.72x in FY2025 Q1 (Threshold: 2.5x).

"The ability to cover interest is strengthening as earnings improve or debt is retired."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)2.832.53⚠️ HIGH
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+66.0+66.0✅ RESILIENT
Forensic Benchmark Context: Pharmacy Retail (n=2 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
₹900.15(+2.92%)
1M Divergence+2.83%
1 Week+2.01%
1 Month+3.21%
6 Months+10.73%
1 Year-4.98%
2 Year+23.09%
3 Year+10.77%
Sector Average (1M)+0.38%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The structural architecture is currently robust. Capital resilience buffers in governance remain well-maintained against forensic benchmarks. Systematic scans of structural transparency and audit trails confirm the absence of material structural stress. Initial structural recovery is visible; monitor for a sustained return to resilience.

MEDPLUS • MARKET STRUCTURE

Stage 2 — Advancing

The company is in a growth phase. Institutional sentiment is highly positive, supported by strong fundamentals and sustained risk reduction.

Stage Transition Prob.94%
Trend QualityStrong
Phase Progression
Phase Progression Score82.5%
Readiness LabelHigh (Phase Transition Imminent)
Probability of Advancing94%
CoinTree Momentum
Composite Z-Score+0.0537σ
Improving momentum strength
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#893 of 2716
Top 32.88% in momentum strength
Timeframe Sparklines
1W+2.0%
1M+3.2%
6M+10.7%
Weinstein Indicators
150 DMA₹832.39
200 DMA₹826.86
150 DMA Slope+1.9780%Rising
Relative Strength+18.22%Leading
Relative Turnover (RTR)1.0778
ParticipationNeutral

PEER COMPARISON

Ranked comparison against sector peers

This company appears relatively stable compared to the Sector Mean (40).
MEDPLUSMedplus Health Services Limited
0 Risk
Sector %ile0th
Delta-5
Active Flags2
Accel+0
Governance

Stable

ENTEROEntero Healthcare Solutions Limited
0 Risk
Sector %ile0th
Delta0
Active Flags3
Accel+0
Governance

Stable

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
10100th %ile
VS Sector Median (8.5)
Balance Sheet Stress
10100th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
10100th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Relative Growth Weakness

2026

Relative Growth Weakness

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY20266,964220496-
FY20256,185150540-
FY20245,66566144-
FY20234,6045090-